JG
RDY icon

Jefferies Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Jefferies Group’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,545
Closed -$61K – 2891
2015
Q2 		$61K Buy
+5,545
New +$61.2K ﹤0.01% 2370

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OAM
Origin Asset Management London, United Kingdom $43.5M AUM 31.63% 1-Year Est. Return

Jefferies Group's RDY Position: Q3 2015 in Review

Jefferies Group sold out of Dr. Reddy's Laboratories (RDY) in Q3 2015, closing a stake of 5,545 shares — an estimated $61K sold.

Jefferies Group first reported a position in RDY in Q2 2015 and held it in 1 quarter. The position peaked at $61K in Q2 2015. 206 funds tracked by Wall St. Rank hold RDY as of Q3 2015.

  • Jefferies Group reported no remaining Dr. Reddy's Laboratories position as of Q3 2015 after selling out during the quarter.
  • Jefferies Group sold 5,545 Dr. Reddy's Laboratories shares in Q3 2015, an estimated $61K.
  • Jefferies Group first reported a position in Dr. Reddy's Laboratories in Q2 2015 and held it in 1 quarter.
  • Jefferies Group's Dr. Reddy's Laboratories position peaked at $61K in Q2 2015.
  • 206 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2015.

Based on Jefferies Group's 13F filing for Q3 2015, filed 13 Nov 2015.